Announcement PDF Q4 FY25 EXL RESULTS & OUTLOOK INVESTOR PRESENTATION February 2026 1 Chair Elixinol Wellness– Gavin Evans (appointed December 2025) 2 • Experienced Founder in healthy food sector: Founder of Openway Food Co and proven architect of vertically integrated, category-leading business models • Strong industry relationships across the supply chain, retail, distribution and investment sectors • Focus on financial discipline: Targeting scalable, high-margin categories and aligning cost base to core revenue drivers • Deep experience in sharp operational execution and M&A Mandate to create a solid foundation for scalable growth New Executive management team with broad industry experience CEO and CFO recently appointed Adam Dimitropoulos Chief Financial Officer Natalie Butler Executive Director & CEO Gavin Evans Non-exec Chair 25 years finance experience, previous positions include CFO at MS Pharma, VP FPA at Stada, Finance & Ops at Amneal, and VP Finance at Actavis 25 years industry experience, previous positions include GM Tom Organics, GM Marketing TSN and L’Oreal International business leader with senior investment banking experience in London and a track record of building food and wellness businesses in Australia, now Chair of EXL. Accomplished Non-Executive Director with 20+ years investment banking experience, holding board roles across FMCG, resources, fintech and not-for-profit, including Chair of Kalgoorlie Gold Mining and Director of Pioneer Credit. 3 Pauline Gately Non-exec Director Elixinol has a bold, ambitious vision for a healthy food roll-up... 4 To build a portfolio of premium- branded health food assets, with Australian manufacturing capabilities and global growth potential. 4 5 5 Australia is a large & high-growth wellness market IMARC Group, Australia Dietary Supplements Market Forecast; Global Wellness Institute, Global Wellness Economy Reports; 2024 Value 2030/2033 Forecast Growth/Position Aust Wellness Market1 AUD 160B AUD 307B by 2033 ~7% CAGR Functional Foods AUD 10.5B AUD 16.5B by 2033 ~5% CAGR Dietary Supplements AUD 5.4B AUD 10.4B by 2033 ~8% CAGR Per Capita Health Spend ~AUD 7,402/year Top 10 globally 1 Aus Wellness Market includes Functional Foods and Beverages, Beauty and Personal Care Products with wellness focus, Preventive and Personalized Medicinal Products, and Others * USD values converted to AUD at an illustrative exchange rate of 1 USD = 1.50 AUD ELIXINOL WELLNESS (ASX:EXL) OVERVIEW Elixinol Wellness: A Sustainable Nutrition & Wellness Company Elixinol Wellness operates a vertically integrated business in Australia and the USA producing, manufacturing and distributing a range of complementary products across key verticals including nutrition, wellness and superfood ingredients. Products are sold through grocery, wholesale and e-commerce channels. Elixinol USA sells high quality Elixinol branded hemp and nutraceutical products. 7 7 Elixinol Wellness is a diversified health and nutrition platform built for longevity and everyday wellness Hemp Foods Australia Mt Elephant Soul Seeds Nutrition The Healthy Chef Elixinol USA Supplements Australian Primary Hemp The Super Food Co Superfoods 8 Wholefood Baking Mixes Healthy Savoury Snacking CBD Supplements Key branding supporting existing and new product introductions 9 9 Diversified distribution channels to both B2B and B2C Retail partners, direct to consumer through e-commerce and white label products 10 10 Healthy Savoury Snacking 10 10 ELIXINOL WELLNESS (ASX:EXL) Q4 FY25 FINANCIAL RESULTS Q4 FY25 Key Highlights ✓ Q4 FY25 revenue of $4.1 million, up 9.5% QoQ, reflecting a seasonally strong quarter ✓ Revenue for FY25 increased compared to FY24 ✓ Diversified revenues through e-commerce sales of Healthy Chef, at higher margins due to product innovation in high growth categories ✓ Re-established dominant position as trusted Hemp supplier to Australian retailers ✓ Strategic focus on higher-margin sales ✓ Structural reduction in cost base and clear path to profitability ✓ Underlying operating cash flow positive1 for the quarter ✓ Solid foundation for organic growth and M&A opportunities to scale the business 1 Underlying operating cash flow excludes finance costs, payments for income taxes and other items) out of cycle payments and non-recurring items). Results are unaudited and subject to review. Revenue growth, lower operating cost base & underlying operating cash flow positive for the quarter 12 13 Strategic focus on higher-margin revenue • Q4 is a seasonally strong quarter • Q4 revenue of $4.1m, up 9.5% QoQ • FY25 revenue of $15.5m, up 3.6% YoY • Improved gross margins through deliberate shift towards higher-margin product & channels • Derisking business through diversified revenues: E-commerce sales of Healthy Chef, up 42% in Q4 FY25 compared to Q4 FY24 • Healthy Chef revenue at higher margins due to product innovation in high-growth categories • Effective transition to streamlined SKUs across retail brands 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 Q1-24 Q2-24 Q3-24 Q4-24 Q1-25 Q2-25 Q3-25 Q4-25 Hemp Foods Australia Australian Primary Hemp Elixinol Americas The Healthy Chef Mt. Elephant Australian Superfood Co Revenue by Key Brands ($M) Revenue Mix FY-25 38.4% 13.8% 47.8% E-commerce Retail 21.2% 24.1% 54.6% E-commerce Bulk ingredients Retail Revenue Mix FY-24 Bulk ingredients 14 Structural reduction in cost base and clear path to profitability • Decrease in operating cost base by approx. 30% in Q4 FY25 v Q4 FY24 • Cost reduction initiatives were accelerated in Q3 FY25 across staffing, marketing & corporate overheads • Underlying operating cash flow positive for the quarter1 • Ongoing opex run-rate significantly lower than historical levels • Two-tranche capital raise completed in H2 totalling $2.5m • Solid foundation for organic growth and M&A opportunities to scale the business 1 Underlying operating cash flow excludes finance costs, payments for income taxes and other items (out of cycle payments and non-recurring items). Results are unaudited and subject to review. 0.0 1.0 2.0 3.0 4.0 5.0 Q1-25 Q2-25 Q3-25 Q4-25 +0.1 -1.5 -1.0 -0.5 0.0 0.5 Q1-25 Q2-25 Q3-25 Q4-25 Revenue by Quarter ($M) EBITDA by Quarter ($M) ELIXINOL WELLNESS (ASX:EXL) FY26 STRATEGIC OUTLOOK 16 • 70–80% of consumers rate wellness as high priority • Millennials and Gen X are the fastest-growing wellness spenders Preventative health is now everyday spending. Longevity is reshaping food & nutrition spend Quantified tailwinds supporting health & wellness spend McKinsey & Company, Future of Wellness Survey; NielsenIQ, Global Health & Wellness Consumer Trends; Global Wellness Institute, Global Wellness Economy Reports; Grand View Research, Australia Functional Foods Market Outlook; IMARC Group, Australia Dietary Supplements Market Forecast • Functional foods growing ~5%+ CAGR, consumers taking a food is medicine approach. • 50–70% of consumers say clean label / natural ingredients influence purchase decisions Everyday food formats drive higher frequency, stickier demand than supplement- only models. • Grocery-led wellness provides stability; DTC supplements deliver higher margin upside • Australia ranks top-10 globally for per-capita wellness spend Diversification across food, supplements and ingredients lowers volatility while preserving growth. Food-First Wellness is embedded in daily life Diversified Product Portfolio Improves Resilience • DTC delivers faster growth, deeper data and higher margins. • Marketing investment concentrated where returns are strongest • Product launches designed for daily use, not complex routines Preventative health is now everyday spending Accelerate DTC Where Growth and Margin Are Highest EXL is executing against the Wellness Megatrends • Retail wellness categories remain early and underdeveloped • We partner with buyers to lead innovation and grow categories, not just shelf space • Focus on products that bring excitement and education into everyday food aisles Retail-led, frequency-driven growth • Hemp demand grows steadily as awareness and distribution expand • As a leading player, we benefit disproportionately as the category scales • Focus on quality, reliable supply, key retail partnerships and margin improvement over time Long-term demand, disciplined execution. Everyday Nutrition Is Where Wellness Scales Category Leadership Compounds as Hemp Grows 17 Metabolic Burn: Capturing the GLP-1 Curious Consumer Interest far exceeds usage 400–500k Australians use GLP-1s today, but interest is much larger. Global data shows 2–3x more consumers are interested, limited by cost, access, and long-term concerns. A large pre-GLP-1 market ~9 million Australians are engaged with metabolic health. Many are GLP-1 curious, ineligible, not ready, or seeking a natural, TGA-regulated alternative or complement. A credible bridge Metabolic Burn supports energy, glucose metabolism, and fat conversion through a clinically informed formula. It fits before, instead of, or alongside pharmaceuticals Protein Waters: Leading Growth in the Protein Category A fast-growing market with a clear winner Australia’s protein supplements market is tracking to ~$1.1B by 2034. Protein water is the growth leader at 8.3% CAGR, ahead of traditional powders. Right format, right consumer, right time Consumers want lighter, clean protein they can drink anytime. Protein water delivers everyday hydration without the heaviness of shakes. Healthy Chef as category innovators With three functional protein waters, Healthy Chef is positioned at the premium end of the fastest-growing segment, offering benefits beyond basic protein. Research and Markets, Australia Protein Supplements Market Forecast (2024) Building a Stronger Brand in a SKU Rationalised Retail Environment In partnership with Innovation validated by Coles World-first sustainable formats and cross- category collaborations are launching with Coles, demonstrating retailer confidence in Mt. Elephant’s ability to drive growth. Brand refresh built for today’s retail reality. We’re evolving Mt. Elephant to be clearer, bolder, and more competitive at shelf, helping it win space as buying decisions get tougher. From niche free-from to mainstream wholefood We’re softening the health message to meet a larger conventional audience. wholefood, better-for-you credentials remain, but taste, indulgence, and convenience lead the experience. 21 21 FY26 Outlook EXL is now operating from a stronger, more efficient cost base, ready to capture growth opportunities and create long-term shareholder value. Operational Momentum • Improve performance off a right- sized cost base • Drive more efficient operations and stronger margins Cost Efficiency • Maintain a structurally lower opex run-rate • Create flexibility to invest in growth initiatives Growth Foundation • Building a platform for sustainable organic growth • Leverage category strengths & consumer demand Strategic Opportunities • Pursue value- accretive M&A to scale the business • Focus on core revenue drivers and disciplined execution Important Notice & Disclaimer The following material is for general information purposes only and should not be relied on for the making of any investment decision. Any investment in Elixinol Wellness Limited ACN 621 479 794 (Elixinol Wellness) is subject to a number of investment risks including the possibility of loss of capital invested and no return of income or payment of dividends. Neither Elixinol Wellness nor any other entity or person in or associated with the Elixinol Wellness group of companies guarantees any return (whether capital or income) or generally the performance of Elixinol Wellness or the price at which its securities may trade. In particular, this presentation is not a recommendation, offer or invitation to subscribe for or purchase Elixinol Wellness securities. This presentation is not exhaustive of all of the information a potential investor, or their professional advisers would require. This presentation does NOT constitute a “Prospectus" or a "Disclosure Document” (as defined in the Corporations Act 2001 (Cth) (Corporations Act)) and has not been, and will not be, lodged with the Australian Securities and Investments Commission or any other regulatory authority. Accordingly, it is not required to contain, and may not necessarily contain, all of the information that a Prospectus or like Disclosure Document would be required to contain pursuant to the Corporations Act. This presentation does not take into account any specific objectives, financial situation or needs of investors. For these and other reasons, you are strongly recommended to obtain your own up to date independent legal, financial and investment advice – those acting without such advice do so at their own risk. This presentation may contain "forward-looking statements" which are not historical facts. Words such as “expect(s)”, “feel(s)”, “believe(s)”, “will”, “may”, “anticipate(s)” and similar expressions are intended to identify forward-looking statements. Any forward-looking statements in this presentation should be considered “at-risk statements” - not to be relied upon as they are subject to known and unknown risks, uncertainties and other factors that may lead to actual results differing from any forward-looking statement. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof and Elixinol Wellness does not undertake any obligation to revise and disseminate forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of or non-occurrence of any events. In addition, the past performance of Elixinol Wellness cannot be assumed as indicative of the future performance. There is NO guarantee of future performance - actual results and future outcomes will in all likelihood differ from those outlined in this Presentation. Neither Elixinol Wellness nor any of its advisers, agents or employees make or give any express or implied representation, warranty or guarantee that the information contained in this presentation or otherwise supplied by or on behalf of Elixinol Wellness is complete or accurate or that it has been or will be audited or independently verified, or that reasonable care has been or will be taken in compiling, preparing or furnishing the relevant information. Elixinol does not take any responsibility for any inference, interpretation, opinion or conclusion that any person may draw or form from this presentation. To the maximum extent permitted at law, Elixinol Wellness and all of its representatives, directors, partners, employees or professional advisers exclude all direct and indirect liability arising out of or in connection with any use or reliance of the information contained or described within this presentation. Other than to the extent required by law (and only to that extent), they do not make any representation or give any assurance, guarantee or warranty (express or implied) as to, nor assume any responsibility or liability for, the authenticity, origin, validity, accuracy, suitability or completeness of, or any errors in or omissions from, any information, statement or opinion contained in this Presentation or any accompanying, previous or subsequent material or presentation. This Presentation is current as at 12 February 2026 22 Q&A Elixinol Wellness Limited (ASX:EXL) Gavin Evans, Non-executive Chair Gavin.evans@elixinolwellness.com Katie Mackenzie, Investor Relations kmackenzie@belleviewir.com.au Suite 2, Level 11, 385 Bourke St, Melbourne VIC 3000 info@elixinolwellness.com www.elixinolwellness.com | @EXLWellness